Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis®

Clinical trial NCT01277705 · COMPLETED

Trial details

NCT number: NCT01277705
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tetanus Diphtheria Acellular Pertussis

Start date: 2002-01-01
Primary completion: 2002-04-01
Enrollment: 806

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.